| Literature DB >> 34046565 |
Andreina Manfredi1, Giulia Cassone2, Caterina Vacchi2, Fabrizio Pancaldi3, Giovanni Della Casa4, Stefania Cerri5, Lisa De Pasquale1, Fabrizio Luppi6, Carlo Salvarani7, Marco Sebastiani1.
Abstract
OBJECTIVES: This study aims to evaluate the diagnostic accuracy of the VECTOR software in patients with connective tissue diseases (CTDs), compared with the reference standard of high-resolution computed tomography (HRCT). PATIENTS AND METHODS: The study included 98 consecutive patients of CTD (24 males, 74 females; median age 66 years; range, 24 to 85 years) with a recent HRCT. Patients were evaluated in a blindly manner by VECTOR and the results obtained by the algorithm were compared with the presence of interstitial lung disease (ILD) according to HRCT.Entities:
Keywords: Connective tissue diseases; VECTOR; diagnosis; interstitial lung disease; screening; velcro crackles
Year: 2020 PMID: 34046565 PMCID: PMC8140864 DOI: 10.46497/ArchRheumatol.2021.7975
Source DB: PubMed Journal: Arch Rheumatol ISSN: 2148-5046 Impact factor: 1.472
Demographic and clinico-radiological features of connective tissue disease patients
| Non-ILD | ILD | Total | |||||||||||
| n | % | Median | IQR | n | % | Median | IQR | n | % | Median | IQR | ||
| Number | 57.2 | 42 | 42.8 | 98 | |||||||||
| Sex | |||||||||||||
| Female | 73.2 | 33 | 78.6 | 74 | 75.5 | 0.61 | |||||||
| Median age (year) | 64 | 21 | 68.5 | 13 | 66 | 18 | 0.08 | ||||||
| Disease duration (month) | 60 | 112 | 78.5 | 99 | 72 | 103 | 0.58 | ||||||
| Smoking | 76.8 | 32 | 76.2 | 75 | 76.5 | 0.96 | |||||||
| Antinuclear antibodies | 53 | 94.6 | 39 | 92.8 | 92 | 92.8 | 0.91 | ||||||
| ENA | 39 | 69.6 | 29 | 69.0 | 68 | 69.4 | 0.98 | ||||||
| Anti-SSA | 25 | 44.6 | 19 | 45.2 | 44 | 44.9 | 0.89 | ||||||
| Rheumatoid factor | 10 | 17.8 | 9 | 21.4 | 19 | 19.4 | 0.79 | ||||||
| Pattern HRCT | |||||||||||||
| UIP | 19 | 19.4 | 19 | 19.4 | |||||||||
| OP | 6 | 6.1 | 6 | 6.1 | |||||||||
| NSIP | 13 | 13.3 | 13 | 13.3 | |||||||||
| LIP | 1 | 1 | 1 | 1 | |||||||||
| Other | 3 | 3.1 | 3 | 3.1 | |||||||||
| Rheumatic diseases | |||||||||||||
| DM | 3 | 5.3 | 4 | 9.5 | 7 | 7.1 | |||||||
| SLE | 7 | 12.5 | 1 | 2.3 | 8 | 8.2 | |||||||
| ASSD | 2 | 3.6 | 4 | 9.5 | 6 | 6.1 | |||||||
| pSS | 21 | 37.5 | 8 | 19.0 | 29 | 29.6 | |||||||
| SSC | 10 | 17.8 | 22 | 52.4 | 32 | 32.6 | |||||||
| UCTD | 13 | 23.2 | 3 | - | 16 | 16.3 | |||||||
| ILD: Interstitial lung disease; IQR: Interquartile range; ENA: Extractable nuclear antigen; Anti-SSA: Anti-Sjögren’s syndrome type A; HRCT: High-resolution computed tomography; UIP: Usual interstitial pneumonia; OP: Organizing pneumonia; NSIP: Nonspecific interstitial pneumonia; LIP: Lymphoid interstitial pneumonia; DM: Dermatomyositis; SLE: Systemic lupus erythematosus; ASSD: Antisynthetase syndrome; pSS: Primitive Sjögren’s syndrome; SSc: Systemic sclerosis; UCTD: Undifferentiated connective tissue disease. | |||||||||||||
Diagnostic accuracy according to high-resolution computed tomography pattern
| n | % | Diagnostic accuracy (%) | |
| Usual interstitial pneumonia | 19 | 19.4 | 89.5 |
| Nonspecific interstitial pneumonia | 13 | 13.3 | 92.3 |
| Organizing pneumonia | 6 | 6.1 | 100 |
| Lymphoid interstitial pneumonia | 1 | 1 | 100 |
| Other | 3 | 3.1 | 100 |
| Normal | 56 | 57.1 | 89.8 |